Dow Up 0.11% Nasdaq Up 0.50%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
14.57 Up 0.43(3.04%) Aug 29, 3:59PM EDT
|After Hours : 14.41 Down 0.16 (1.10%) Aug 29, 7:58PM EDT
Prev Close:14.14
Open:14.20
Bid:14.35 x 1000
Ask:14.49 x 400
1y Target Est:33.50
Beta:2.95
Next Earnings Date:N/A
Day's Range:14.15 - 14.80
52wk Range:4.10 - 27.63
Volume:2,905,036
Avg Vol (3m):2,900,020
Market Cap:770.87M
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARWRUp 3.04%770.87M
APNTDown 5.29%10.48M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,274.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-1.04
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.86

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback